Table 2. Participant sample demographics (n=203).
Characteristic | n (%) |
---|---|
Age, Mean (SD) | 53.1 years (16.1 years) |
Age Range | 18-86 years |
Sex | |
Male | 73 (36.5) |
Female | 127 (63.5) |
Employment Status | |
Disability | 88 (43.3) |
Full time | 32 (15.8) |
Part time | 15 (7.4) |
Retired | 67 (33.0) |
Student | 5 (2.5) |
Unemployed | 17 (8.4) |
Social assistance | 7 (3.4) |
Types of Pain | |
Abdominal pain | 33 (16.3) |
Arthritis | 87 (42.9) |
Back pain | 159 (78.3) |
CRPS | 45 (22.2) |
Diabetic neuropathy | 16 (7.9) |
Facial pain | 16 (7.9) |
Fibromyalgia | 49 (24.1) |
Headaches | 78 (38.4) |
Neck pain | 95 (46.8) |
Pelvic pain | 35 (17.2) |
Shoulder pain | 97 (47.8) |
Other pain | 50 (24.6) |
Comorbidities | |
Acute coronary syndrome | 5 (2.5) |
ADD/ADHD | 7 (3.4) |
Anxiety disorder(s) | 91 (44.8) |
Arrhythmia | 15 (7.4) |
Bipolar disorder | 6 (3.0) |
COPD/Asthma | 31 (15.3) |
Depression | 95 (46.8) |
Diabetes | 35 (17.2) |
Dyslipidemia | 39 (19.2) |
Hypertension | 58 (28.6) |
PTSD | 33 (16.3) |
Schizophrenia | 0 (0) |
Stroke | 4 (2) |
No comorbidities | 24 (11.8) |
Family History | |
Schizophrenia | 8 (3.9) |
Bipolar disorder | 15 (7.4) |
ADD/ADHD | 21 (10.3) |
Addiction to Alcohol, Street drugs or prescription drugs | 35 (17.2) |
No family history of these conditions | 131 (64.5) |
Pharmaceutical Cannabinoid Use | |
Nabilone | 8 (3.9) |
Sativex | 0 (0) |
ADD – Attention deficit disorder, ADHD – Attention deficit hyperactivity disorder, COPD – Chronic obstructive pulmonary disease, PTSD – Posttraumatic stress disorder